The 3rd Annual Innate Killer SummitEurope covers topics such as:
- Bringing the Next Wave of Innate Immunotherapies to Market
- Utilising the Innate Immune System to Overcome Tumour Resistance Mechanisms & Facilitate a wider Immune Response
- Reconsidering Innate Cell Scarcity & Phenotypic Complexity to Promote an Effective & Efficient Engraftment Strategy
- Evaluating the Role of Genetic Engineering to Reduce Immunogenicity & Increase Persistence of Innate Cell Therapies
- Bringing the Next Wave of Innate Immunotherapies to Market
- Utilising the Innate Immune System to Overcome Tumour Resistance Mechanisms & Facilitate a wider Immune Response
- Reconsidering Innate Cell Scarcity & Phenotypic Complexity to Promote an Effective & Efficient Engraftment Strategy
- Evaluating the Role of Genetic Engineering to Reduce Immunogenicity & Increase Persistence of Innate Cell Therapies
- Looking Beyond NK Allogeneic Therapies with Cell Engager & Combined Modality Strategies
- Re-Imagining Predictive Modelling to Break Translational Barriers in Innate Cell Therapy Development
- Harnessing the Power of Myeloid Cells to Achieve Clinical Efficacy in the Next Generation of Innate Cell Therapies
The 3rd Annual Innate Killer SummitEurope might be held in London, United Kingdom in Oct 2024.
